The impact of Foxp3 + regulatory T‐cells on CD8 + T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Mikhaël Attias, Ciriaco A. Piccirillo |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
CKLF‐like MARVEL transmembrane domain‐containing superfamily 8 (CMTM8) promotes Notch signalling to maintain CD8 + T cell‐ and NK cell‐dependent tumour immune escape
par: Fanglin Li, et autres
Publié: (2026)
par: Fanglin Li, et autres
Publié: (2026)
Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
par: Gautham Gampa, et autres
Publié: (2024)
par: Gautham Gampa, et autres
Publié: (2024)
Reprogramming tumour‐associated macrophages in breast cancer via si‐FOXM1‐loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy
par: Yali Gao, et autres
Publié: (2026)
par: Yali Gao, et autres
Publié: (2026)
A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
par: Marvin Xuejun Xu, et autres
Publié: (2025)
par: Marvin Xuejun Xu, et autres
Publié: (2025)
V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma
par: Shasha Jin, et autres
Publié: (2024)
par: Shasha Jin, et autres
Publié: (2024)
Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis
par: Takahiro Sumimoto, et autres
Publié: (2024)
par: Takahiro Sumimoto, et autres
Publié: (2024)
Induction of IL‐9‐producing CD8 + T cells by ascochlorin derivatives
par: Natsumi Imano, et autres
Publié: (2026)
par: Natsumi Imano, et autres
Publié: (2026)
Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction
par: David F. Colón, et autres
Publié: (2024)
par: David F. Colón, et autres
Publié: (2024)
The PARP inhibitor rucaparib blocks SARS‐CoV‐2 virus binding to cells and the immune reaction in models of COVID‐19
par: Henrietta Papp, et autres
Publié: (2024)
par: Henrietta Papp, et autres
Publié: (2024)
Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting
par: Svetlana Obrenovic, et autres
Publié: (2025)
par: Svetlana Obrenovic, et autres
Publié: (2025)
Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells
par: Lin Lin, et autres
Publié: (2025)
par: Lin Lin, et autres
Publié: (2025)
Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning
par: Dongxue Yan, et autres
Publié: (2025)
par: Dongxue Yan, et autres
Publié: (2025)
Glycolytic metabolism of CD8 + T‐cells affects susceptibility to human leukocyte antigen‐mediated abacavir‐induced hypersensitivity
par: Takeshi Susukida, et autres
Publié: (2026)
par: Takeshi Susukida, et autres
Publié: (2026)
Activation of autophagy mediated by PI3K/Akt/mTOR signalling cascade alleviates impaired adipose‐derived stem cell osteogenesis in a diabetic microenvironment
par: Fangzhi Lou, et autres
Publié: (2025)
par: Fangzhi Lou, et autres
Publié: (2025)
Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer
par: Timothée David, et autres
Publié: (2024)
par: Timothée David, et autres
Publié: (2024)
7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction
par: Ju‐Ying Tsai, et autres
Publié: (2025)
par: Ju‐Ying Tsai, et autres
Publié: (2025)
2‐Hydroxyl hispolon reverses high glucose‐induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO‐1 pathways
par: Ta‐Jung Wang, et autres
Publié: (2025)
par: Ta‐Jung Wang, et autres
Publié: (2025)
Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin‐degrading enzyme, a new molecular vulnerability in multiple myeloma
par: Laetitia Lesire, et autres
Publié: (2026)
par: Laetitia Lesire, et autres
Publié: (2026)
Monovalent mannose‐glycoconjugates of sulforaphane reprogram human dendritic cells via NFATc1 to induce immune tolerance under inflammatory conditions
par: María Elena Angarita‐Planchez, et autres
Publié: (2025)
par: María Elena Angarita‐Planchez, et autres
Publié: (2025)
Inhibition of the calcineurin/forkhead box O1/fatty acid binding protein 4 pathway prevents SERCA2 dysfunction‐induced foam cell formation and atherosclerosis
par: Beibei Zhu, et autres
Publié: (2025)
par: Beibei Zhu, et autres
Publié: (2025)
Piezo1‐mediated regulation of smooth muscle cell volume in response to enhanced extracellular matrix rigidity
par: Robert T. Johnson, et autres
Publié: (2024)
par: Robert T. Johnson, et autres
Publié: (2024)
PLGA‐particle‐based vaccine induces SARS‐CoV‐2‐specific antibody and T‐cell responses
par: Dennis Horvath, et autres
Publié: (2026)
par: Dennis Horvath, et autres
Publié: (2026)
Baclofen modulates the immune response after spinal cord injury with locomotor benefits
par: Nídia de Sousa, et autres
Publié: (2025)
par: Nídia de Sousa, et autres
Publié: (2025)
GI‐Y2, a novel gasdermin D inhibitor, attenuates sepsis‐induced myocardial dysfunction by inhibiting gasdermin D‐mediated pyroptosis in macrophages
par: Yiling Mei, et autres
Publié: (2025)
par: Yiling Mei, et autres
Publié: (2025)
Blockade of CaV3 calcium channels and induction of G0/G1 cell cycle arrest in colon cancer cells by gossypol
par: Osbaldo Lopez‐Charcas, et autres
Publié: (2024)
par: Osbaldo Lopez‐Charcas, et autres
Publié: (2024)
Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses
par: De‐Kui Qiu, et autres
Publié: (2026)
par: De‐Kui Qiu, et autres
Publié: (2026)
A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye
par: Yiqin Dai, et autres
Publié: (2024)
par: Yiqin Dai, et autres
Publié: (2024)
Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance
par: Ignatios Ioakeim‐Skoufa, et autres
Publié: (2025)
par: Ignatios Ioakeim‐Skoufa, et autres
Publié: (2025)
Circular RNA regulatory role in pathological cardiac remodelling
par: Alessia Bibi, et autres
Publié: (2024)
par: Alessia Bibi, et autres
Publié: (2024)
Role of inflammasomes in endothelial dysfunction
par: Jimin Wu, et autres
Publié: (2024)
par: Jimin Wu, et autres
Publié: (2024)
α‐Linolenic acid suppresses Th17 cell differentiation to mitigate allergic rhinitis by binding to Lyn kinase in mast cells
par: Yuejin Wang, et autres
Publié: (2026)
par: Yuejin Wang, et autres
Publié: (2026)
Opioids in breast cancer: Between analgesia and modulation of tumour progression
par: Marianna Ciwun, et autres
Publié: (2026)
par: Marianna Ciwun, et autres
Publié: (2026)
Exploring drug mechanisms through single‐cell proteomics
par: Yuzhi Sun, et autres
Publié: (2026)
par: Yuzhi Sun, et autres
Publié: (2026)
Cardiotoxicity of BRAF/MEK inhibitors
par: Katharina Seuthe, et autres
Publié: (2026)
par: Katharina Seuthe, et autres
Publié: (2026)
Insight into the regulatory mechanism of β‐arrestin2 and its emerging role in diseases
par: Meng Qi, et autres
Publié: (2024)
par: Meng Qi, et autres
Publié: (2024)
Vitamin D deficiency induces erectile dysfunction: Role of superoxide and Slpi
par: Miguel A. Olivencia, et autres
Publié: (2025)
par: Miguel A. Olivencia, et autres
Publié: (2025)
Structure‐based discovery of thiamine uptake inhibitors
par: Florian Gabriel, et autres
Publié: (2025)
par: Florian Gabriel, et autres
Publié: (2025)
Schwann cell TRPA1 elicits reserpine‐induced fibromyalgia pain in mice
par: Evelyne Silva Brum, et autres
Publié: (2024)
par: Evelyne Silva Brum, et autres
Publié: (2024)
Smooth muscle cell Piezo1 is essential for phenotypic switch and neointimal hyperplasia
par: Fei‐Ran Zhang, et autres
Publié: (2025)
par: Fei‐Ran Zhang, et autres
Publié: (2025)
Only time will tell: Modelling the kinetics of covalent inhibitors
par: Madeeha I. Ali, et autres
Publié: (2026)
par: Madeeha I. Ali, et autres
Publié: (2026)
Documents similaires
-
CKLF‐like MARVEL transmembrane domain‐containing superfamily 8 (CMTM8) promotes Notch signalling to maintain CD8 + T cell‐ and NK cell‐dependent tumour immune escape
par: Fanglin Li, et autres
Publié: (2026) -
Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
par: Gautham Gampa, et autres
Publié: (2024) -
Reprogramming tumour‐associated macrophages in breast cancer via si‐FOXM1‐loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy
par: Yali Gao, et autres
Publié: (2026) -
A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
par: Marvin Xuejun Xu, et autres
Publié: (2025) -
V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma
par: Shasha Jin, et autres
Publié: (2024)